Robotic-assisted Hysterectomy: Single- vs. Multi-port Laparoscopic Access
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03373513 |
|
Recruitment Status :
Not yet recruiting
First Posted : December 14, 2017
Last Update Posted : September 6, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Activity, Motor Pain Wound | Procedure: Robotic single-site Hysterectomy Procedure: Laparoscopic hysterectomy | Not Applicable |
The study is scheduled to start February 2018 and compares robotic single-site hysterectomy to conventional multiport hysterectomy. Procedures are performed by an experienced two-surgeon team. Patients are randomized to either conventional multiport hysterectomy (N=62) or R-SSH (N=62). Eligibility criteria are the same as for study 1. Patient's satisfaction with body image and cosmesis is assessed at different time points pre- and postoperatively by means of validated cosmesis scales and Body Image Questionnaire. Postoperative pain and analgesia use will be registered as well as secondary outcome parameters as described above. A follow-up at 1, 3 and 6 month include evaluation of the scar and registration of port-site hernias and vaginal dehiscence or other complications. Interviews and diaries will include time of return to home and work, daily activities including sexuality The R-SSH is performed using da Vinci, Xi robotic system. One single port, diameter 2 cm is applied. Applying an additional assistant port is defined conversion of procedure The laparoscopy is performed using our standard equipment and 4 trocars, 5 mm each.
Socio-economical consequences of R-SSH versus conventional laparoscopic hysterectomy Study details in preparation
Sample size calculation was based a previous study on fast track hysterectomy, which showed a difference in return to work of 4 days. 62 women in each group is needed with standard deviation ±8 and a power of 80%. To include those not working, we calculated that with an expected visual analog pain score of 0.86 ±0.2 and 62 in each group the sample was sufficient to detect of difference of 0.1 in visual analog pain score with a power of 80%. All calculation are based on two-sided testing with alpha of 0.05.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 124 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Women are randomized to either robotic single site or multi port lapsoscopic hystrectomy |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Robotic-assisted Hysterectomy: Single- vs. Multi-port Laparoscopic Access |
| Estimated Study Start Date : | February 1, 2019 |
| Estimated Primary Completion Date : | January 1, 2022 |
| Estimated Study Completion Date : | December 1, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Robotic single-site hysterectomy
Robotic single-site hysterectomy is performed in this arm
|
Procedure: Robotic single-site Hysterectomy
Robotic assisted Periumbilical single incision hysterectomy |
|
Active Comparator: Multiport Laparoscopy
Multiport Laparoscopic hysterectomy is performed in this other arm
|
Procedure: Laparoscopic hysterectomy
Multiport laparoscopic hysterectomy |
- Return-to-work [ Time Frame: up to six months after operation or until work is resumed, whichever came first ]Time from operation to return work
- Pain measured by subjective score [ Time Frame: Visual analogue pain score first, second, third, fourth, fifth, and six months after operation ]Visual analogue pain score with a minimum of '0' up to '10' on a 10 cm continious scale
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | women undergoing hysterectomy |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- hysterectomy on benign indication,
- American Society of Anesthetists group 1 or 2,
- BMI less than 35 kg/m2
- uterine size less than 300 g estimated by ultrasound, using Ferraris formula.
Exclusion Criteria:
- adhesions
- prior extensive abdominal surgery
- prior midline incision,
- cutis laxa of abdomen surgery
- endometriosis
- more than 1 cesarean section
- malignant disease
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03373513
| Contact: Finn F Lauszus, MD,PhD | 28495640 | finlau@rm.dk |
| Denmark | |
| Gynecology Dept. Herning Hospital | |
| Herning, Denmark, 7400 | |
| Principal Investigator: | Finn F Lauszus, MD,PhD | Gynecology Department, Herning Hospital |
Documents provided by Finn Friis Lauszus, Herning Hospital:
| Responsible Party: | Finn Friis Lauszus, Research Specialist, Senoir Consultant, Assistant Professor, Herning Hospital |
| ClinicalTrials.gov Identifier: | NCT03373513 |
| Other Study ID Numbers: |
R-SSH |
| First Posted: | December 14, 2017 Key Record Dates |
| Last Update Posted: | September 6, 2018 |
| Last Verified: | September 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | via meeting, posters, abstracts, and publications |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Return-to-work, Visual analogue pain score, Cosmesis |

